Antiphospholipid syndrome is one of the more common acquired causes of
hypercoagulability. Its major presentations are thrombotic (arterial, venous, or …

The antiphospholipid syndrome is an autoimmune condition in which venous or arterial
thrombosis is a primary clinical feature. The other primary clinical feature is adverse …

Antiphospholipid syndrome (APS) is an autoimmune disease characterized by the presence
of antiphospholipid antibodies, such as lupus anticoagulant, anticardiolipin antibodies and …

Antiphospholipid syndrome spans many medical disciplines. Classic criteria include the
presence of anticardiolipin antibody or lupus anticoagulant with typical complications of …

Antiphospholipid Syndrome (APS) is a form of immune mediated thrombophilia, presenting
as recurrent thrombotic events and pregnancy morbidity, in association with positive …

The antiphospholipid syndrome (APS) is defined by the development of venous and/or
arterial thromboses, often multiple, and pregnancy morbidity (mainly, recurrent fetal losses) …

Antiphospholipid syndrome is an autoimmune systemic disorder characterized by arterial,
venous, or small vessel thrombosis and/or recurrent early pregnancy loss, fetal loss, or …

Antiphospholipid syndrome (APS) is an autoimmune disease characterised by the presence
of antiphospholipid antibodies (aPL). The antibodies currently included in the classification …

The antiphospholipid syndrome is a prothrombotic disorder associated with autoantibodies.
It is associated with obstetrical complications (mainly spontaneous abortion) as well as …

Antiphospholipid syndrome (APS) is an autoimmune prothrombotic disease characterized
by thrombosis and/or pregnancy complications caused by antiphospholipid antibodies …